<DOC>
	<DOCNO>NCT02880683</DOCNO>
	<brief_summary>A single-center feasibility study patient undergoing cardiac catheterization , investigate acute hemodynamic effect transvenous cardiac autonomic nerve stimulation .</brief_summary>
	<brief_title>Cardiac Output Autonomic Stimulation Therapy Heart Failure ( COAST-HF ) - Human NeuroCatheter Study</brief_title>
	<detailed_description>A single-center feasibility study perform patient undergo planned cardiac catheterization . This study investigate feasibility NeuroTronik CANS Therapyâ„¢ System improve acute hemodynamics . Purpose-built stimulation catheter percutaneously insert upper venous structure near heart via right femoral vein leave subclavian vein access use standard introducers technique . Subjects instrumented leave ventricular femoral artery catheter pressure measurement stimulate approximately 60 minute . Baseline hemodynamic measure collect stimulation compare measured value stimulation . Following completion protocol , in-dwelling equipment catheter remove .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Cardiac Output , Low</mesh_term>
	<criteria>Stable symptomatic heart failure New York Heart Association Class II III Normal Sinus Rhythm Unable gain arterial venous access use standard percutaneous technique New York Heart Association Class IV Patient take amiodarone antiarrhythmic therapy Patients implanted pacemaker , ICD , CRT device Patients CABG , PCI enzymepositive MI within prior month Patients preexist carotid artery cerebral disease Patients hypertrophic obstructive cardiomyopathy infiltrative cardiomyopathy ( e.g . amyloidosis , sarcoidosis ) Patients hospitalized heart failure require use heart failure IV therapy within 30 day enrollment ( measured release ) Patients current prior vagal nerve simulator Patients renal failure Patients hepatic failure Patients narrow angle glaucoma Patients pregnant Patients life expectancy &lt; 12 month per physician judgment Patients allergy fentanyl , midazolam , propofol , egg , egg product , soybean , soy product</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Electrical Stimulation Therapy</keyword>
	<keyword>Parasympathetic Nervous System</keyword>
	<keyword>Sympathetic Fibers</keyword>
	<keyword>Post Ganglionic</keyword>
	<keyword>Congestive Heart Failure</keyword>
	<keyword>Heart Failure</keyword>
</DOC>